Altair Nanotechnologies signs agreement with Lilly

May 3, 2006 – Altair Nanotechnologies Inc. (ALTI), a supplier of advanced ceramic nanomaterials, announced it has entered into a collaborative research, license and commercialization agreement with the Elanco Animal Health Division of Eli Lilly and Co. The agreement provides Elanco with exclusive rights to develop animal health products using Altairnano’s nanotechnology-based products.

The agreement establishes the framework under which Altairnano and Elanco may commercialize animal health products using Altairnano technology.


Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.